RxDoctor Payments Data

Joseph Muscarella, DO

Otolaryngology/Facial Plastic Surgery · Williamsville, NYNPI 1457302366

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,454, 3.7 times the $391 reported in 2019.

$5,653in general payments, 2019–2025

Across 66 payments — averaging $85.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$803
  • Smith+Nephew$692
  • GSK$677
  • Integra Lifesciences Corporation$473
  • Stryker$403
  • Inspire Medical Systems, Inc.$357
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$5,653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,653 in reported general payments places this provider in the 70th percentile of 48 otolaryngology/facial plastic surgery providers in New York.

See all otolaryngology/facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$94,302
Medicare patients
194
Services billed
525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,688
Ipratropium Bromide37$987
Fluticasone Propionate55$854
Azelastine Hcl23$563
Mupirocin32$215
CefuroximeCefuroxime Axetil13$169
Amitriptyline Hcl17$119
Levothyroxine Sodium13$37

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Williamsville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →